research 71 manabuInstructor

Areas of Interest
Aryl Hydrocarbon Receptor (AHR) in liver and colorectal disease

 

Biography

After receiving a bachelor’s degree in pharmaceutical sciences in 1998, Dr. Nukaya earned a Ph.D. in 2004 from Hokkaido University Graduate School of Pharmaceutical Sciences in Japan. Dr. Nukaya joined the laboratory at McArdle Laboratory for Cancer Research at the University of Wisconsin at Madison under Professor Christopher Bradfield in 2004 to engage in postdoctoral research. Dr. Nukaya conducted signature research efforts on understanding the toxic effects of “dioxin,” an environmental toxin in the liver. From 2009, Dr. Nukaya has participated in basic and translational research focused on chemoprevention of intestinal bowel disease and colorectal cancer with Dr. Gregory Kennedy, Director of Gastrointestinal Surgery at University of Alabama at Birmingham. Dr. Nukaya’s research interest is in the characterization of Aryl Hydrocarbon Receptor (AHR) in liver and colorectal disease.

Education

Undergraduate
School of Pharmaceutical Science, Hokkaido University (Sapporo. Hokkaido. JAPAN)
Pharmaceutical Science

Ph.D.
Graduate School of Pharmaceutical Science, Hokkaido University (Sapporo. Hokkaido. JAPAN)
Pharmaceutical Science


Contact

Campus Address
WTI 603

Phone
205-934-6315

E-mail
manabu@uab.edu